SlideShare a Scribd company logo
1 of 14
Download to read offline
Immunoassay validation for monitoring ruminant
proteins in aquafeed
L.W.D. van Raamsdonk, M. Bremer, RIKILT Wageningen

R. Margry, R. van Kaathoven, CCL, Veghel
Animal proteins monitoring

•

Microscopy: screening; visible particles

•

PCR: identification; DNA

•

Near Infrared spectroscopy / microscopy

•

Immunoassays: screening or confirmation; proteins

•

Other

L.W.D. van Raamsdonk et al., Beijing, Feedsafety conference, 12-9-2012
Animal proteins in aquafeed

Aquafeed

Non-ruminant PAP

25%
2%
Fishmeal

10% gut content
Feed for weaning
ruminants

5%
L.W.D. van Raamsdonk et al., Beijing, Feedsafety conference, 12-9-2012
Animal proteins in aquafeed
EFSA critical limit: 2% ruminant-PAP in
non-ruminant PAP (EFSA, 2011)
Concentration of PAP in ruminant feed:
0.25 * 0.1 * 0.05 = 0.00125%
LOD microscopy: 0.0025 %

(Veys et al., 2009)

EFSA critical limit: 0.1% AP in
feed (EFSA, 2011)

Current scenario: 0.000025% of
ruminant PAP in ruminant feed

L.W.D. van Raamsdonk et al., Beijing, Feedsafety conference, 12-9-2012
Animal proteins in aquafeed
Non-ruminant PAP

aquafeed

monitoring

2%

< 2%:
Certification for aquafeed

25%

fishmeal

10%

Ruminant feed

5%

< 0.1%:
Approved as feed

L.W.D. van Raamsdonk et al., Beijing, Feedsafety conference, 12-9-2012
Immunoassays

(EFSA, 2011)
L.W.D. van Raamsdonk et al., Beijing, Feedsafety conference, 12-9-2012
Immunoassay validation; in house validation MELISA-TEK
Matrix: porcine proteins

RR 1 (133°C)

18.0

RR 3 (141°C)
RR 4 (145°C)

Mean OD sample - Mean OD blank (450nm)

RR 2 (137°C)

16.0
14.0
12.0
10.0
8.0
6.0
4.0
2.0
0.0
0.0

0.5

1.0
Spike rate (%)

1.5

2.0

L.W.D. van Raamsdonk et al., Beijing, Feedsafety conference, 12-9-2012
Immunoassay validation; in house validation MELISA-TEK

•

Specificity and robustness
TN

FP

Porcine PAP

27

0

Poultry PAP

21

1

Other material *

9

0

Milk powder

2

0

Threshold: mean OD ratio + 3 * SD
*: blood plasma, porcine DCP/TCP, feather meal, fish meal, gelatine

L.W.D. van Raamsdonk et al., Beijing, Feedsafety conference, 12-9-2012
Immunoassay validation; interlaboratory study

•

MELISA-TEK and Reveal

•

16 participants

•

Three parts: training samples, entrance test, final study

•

After entrance test: 14 participants

•

Period: January to May 2012

•

AOAC guidelines, as far as applicable

L.W.D. van Raamsdonk et al., Beijing, Feedsafety conference, 12-9-2012
Immunoassay validation; results Melisa-Tek

•

Accuracy (n=84)
133 ºC
Blank

137 ºC

98.8%

0.5%

100%

1.0%

100%

100%

2.0%

100%

100%

L.W.D. van Raamsdonk et al., Beijing, Feedsafety conference, 12-9-2012
Immunoassay validation; results Reveal

•

Accuracy (n=84)
133 ºC
Blank

137 ºC

97.0%

0.5%

100%

1.0%

98.8%

98.8%

2.0%

100%

100%

L.W.D. van Raamsdonk et al., Beijing, Feedsafety conference, 12-9-2012
Immunoassay; future strategy

•

Current situation: performance limit (0.5% < 2.0%) approved

•

Future target: performance limit: 0.1%

•

Option: concentration experiments for target (= troponine)

L.W.D. van Raamsdonk et al., Beijing, Feedsafety conference, 12-9-2012
Immunoassay; conclusions

•

Immunoassays (Melisa-Tek and Reveal) are validated at
0.5% and higher with PAP as matrix

•

A strategy with immunoassays will avoid the presence of
positive signals for legally applied ingredients

•

The design of the study can be used as guideline for future
studies with qualitative results

•

Application of immunoassays after muscle concentration
could be feasible to reach the 0.1% performance limit
L.W.D. van Raamsdonk et al., Beijing, Feedsafety conference, 12-9-2012
THANK YOU

More Related Content

What's hot

3. Ruth White syphilis presentation march 2019 (rw)
3. Ruth White syphilis presentation march 2019 (rw)3. Ruth White syphilis presentation march 2019 (rw)
3. Ruth White syphilis presentation march 2019 (rw)PHEScreening
 
Cd rom 8_optional_molecular_qc
Cd rom 8_optional_molecular_qcCd rom 8_optional_molecular_qc
Cd rom 8_optional_molecular_qcOsmanmohamed38
 
Assay Standardisation - how this leads to improved patient results
Assay Standardisation - how this leads to improved patient resultsAssay Standardisation - how this leads to improved patient results
Assay Standardisation - how this leads to improved patient resultsWalt Whitman
 
A field-deployable automatic nucleic acid extraction and insulated isothermal...
A field-deployable automatic nucleic acid extraction and insulated isothermal...A field-deployable automatic nucleic acid extraction and insulated isothermal...
A field-deployable automatic nucleic acid extraction and insulated isothermal...Simon Chung - genereach
 
Thornton NAAT
Thornton NAATThornton NAAT
Thornton NAATDSHS
 
4th Year Project
4th Year Project4th Year Project
4th Year ProjectDenis Ryan
 
Molecualr diagnostics ,comparison with roche hbv kit
Molecualr diagnostics ,comparison with roche hbv kitMolecualr diagnostics ,comparison with roche hbv kit
Molecualr diagnostics ,comparison with roche hbv kitgrace tang
 
Serigene Nonconfidential 03 15 2012
Serigene Nonconfidential 03 15 2012Serigene Nonconfidential 03 15 2012
Serigene Nonconfidential 03 15 2012silyin
 
Testing for COVID-19 with Antibody and PCR Tests in Low Resource Areas
Testing for COVID-19 with Antibody and PCR Tests in Low Resource AreasTesting for COVID-19 with Antibody and PCR Tests in Low Resource Areas
Testing for COVID-19 with Antibody and PCR Tests in Low Resource AreasRomulo De Castro
 
Gene disc® rapid microbiology system
Gene disc® rapid microbiology systemGene disc® rapid microbiology system
Gene disc® rapid microbiology systemdanisandominguez
 
Results dog dna tests
Results dog dna testsResults dog dna tests
Results dog dna testsp1984sha04
 
ApolloDx's mDx Platform - Real-Time Results Transmitted Instantly
ApolloDx's mDx Platform - Real-Time Results Transmitted InstantlyApolloDx's mDx Platform - Real-Time Results Transmitted Instantly
ApolloDx's mDx Platform - Real-Time Results Transmitted InstantlyApolloDx
 
Blood Culture Contamination at RUMC, A clinicians Perspective
Blood Culture Contamination at RUMC, A clinicians PerspectiveBlood Culture Contamination at RUMC, A clinicians Perspective
Blood Culture Contamination at RUMC, A clinicians PerspectiveLuis Beverido
 

What's hot (19)

3. Ruth White syphilis presentation march 2019 (rw)
3. Ruth White syphilis presentation march 2019 (rw)3. Ruth White syphilis presentation march 2019 (rw)
3. Ruth White syphilis presentation march 2019 (rw)
 
Cd rom 8_optional_molecular_qc
Cd rom 8_optional_molecular_qcCd rom 8_optional_molecular_qc
Cd rom 8_optional_molecular_qc
 
Canine Parvovirus Rapid Test
Canine Parvovirus Rapid TestCanine Parvovirus Rapid Test
Canine Parvovirus Rapid Test
 
Assay Standardisation - how this leads to improved patient results
Assay Standardisation - how this leads to improved patient resultsAssay Standardisation - how this leads to improved patient results
Assay Standardisation - how this leads to improved patient results
 
A field-deployable automatic nucleic acid extraction and insulated isothermal...
A field-deployable automatic nucleic acid extraction and insulated isothermal...A field-deployable automatic nucleic acid extraction and insulated isothermal...
A field-deployable automatic nucleic acid extraction and insulated isothermal...
 
Developing a Test for COVID-19 at Michigan Medicine
Developing a Test for COVID-19 at Michigan MedicineDeveloping a Test for COVID-19 at Michigan Medicine
Developing a Test for COVID-19 at Michigan Medicine
 
Thornton NAAT
Thornton NAATThornton NAAT
Thornton NAAT
 
4th Year Project
4th Year Project4th Year Project
4th Year Project
 
Microbioloy and clinical interaction ...
Microbioloy and clinical interaction                                         ...Microbioloy and clinical interaction                                         ...
Microbioloy and clinical interaction ...
 
Molecualr diagnostics ,comparison with roche hbv kit
Molecualr diagnostics ,comparison with roche hbv kitMolecualr diagnostics ,comparison with roche hbv kit
Molecualr diagnostics ,comparison with roche hbv kit
 
Serigene Nonconfidential 03 15 2012
Serigene Nonconfidential 03 15 2012Serigene Nonconfidential 03 15 2012
Serigene Nonconfidential 03 15 2012
 
Testing for COVID-19 with Antibody and PCR Tests in Low Resource Areas
Testing for COVID-19 with Antibody and PCR Tests in Low Resource AreasTesting for COVID-19 with Antibody and PCR Tests in Low Resource Areas
Testing for COVID-19 with Antibody and PCR Tests in Low Resource Areas
 
EMERGING CHALLENGES IN DIAGNOSTIC MICROBIOLOGY (Overcoming with Newer Approac...
EMERGING CHALLENGES IN DIAGNOSTIC MICROBIOLOGY(Overcoming with Newer Approac...EMERGING CHALLENGES IN DIAGNOSTIC MICROBIOLOGY(Overcoming with Newer Approac...
EMERGING CHALLENGES IN DIAGNOSTIC MICROBIOLOGY (Overcoming with Newer Approac...
 
Gene disc® rapid microbiology system
Gene disc® rapid microbiology systemGene disc® rapid microbiology system
Gene disc® rapid microbiology system
 
Bax Q7
Bax Q7Bax Q7
Bax Q7
 
Results dog dna tests
Results dog dna testsResults dog dna tests
Results dog dna tests
 
online resume
online resumeonline resume
online resume
 
ApolloDx's mDx Platform - Real-Time Results Transmitted Instantly
ApolloDx's mDx Platform - Real-Time Results Transmitted InstantlyApolloDx's mDx Platform - Real-Time Results Transmitted Instantly
ApolloDx's mDx Platform - Real-Time Results Transmitted Instantly
 
Blood Culture Contamination at RUMC, A clinicians Perspective
Blood Culture Contamination at RUMC, A clinicians PerspectiveBlood Culture Contamination at RUMC, A clinicians Perspective
Blood Culture Contamination at RUMC, A clinicians Perspective
 

Similar to Raamsdonk beijing immunoassay validation v2

Dr. Brian Payne - PCV2: Diagnostics, Control, Protection, and Efficacy Measures
Dr. Brian Payne - PCV2: Diagnostics, Control, Protection, and Efficacy MeasuresDr. Brian Payne - PCV2: Diagnostics, Control, Protection, and Efficacy Measures
Dr. Brian Payne - PCV2: Diagnostics, Control, Protection, and Efficacy MeasuresJohn Blue
 
Cladman wendy cv and addendum 2012
Cladman wendy  cv and addendum 2012Cladman wendy  cv and addendum 2012
Cladman wendy cv and addendum 2012Wendy Cladman
 
Cladman wendy cv 2012
Cladman wendy  cv 2012Cladman wendy  cv 2012
Cladman wendy cv 2012Wendy Cladman
 
Cladman, wendy cv and addendum
Cladman, wendy  cv and addendum Cladman, wendy  cv and addendum
Cladman, wendy cv and addendum Wendy Cladman
 
A Novel approach for quantitative real-time particle analysis of lentiviral v...
A Novel approach for quantitative real-time particle analysis of lentiviral v...A Novel approach for quantitative real-time particle analysis of lentiviral v...
A Novel approach for quantitative real-time particle analysis of lentiviral v...Myriade
 
Cambridge oncometrix 230317
Cambridge oncometrix 230317Cambridge oncometrix 230317
Cambridge oncometrix 230317Dmitry Soloviev
 
Gardner, lynn (atlanta_3)[1][1]
Gardner, lynn (atlanta_3)[1][1]Gardner, lynn (atlanta_3)[1][1]
Gardner, lynn (atlanta_3)[1][1]ORALFLUIDLEADTEST
 
Gardner, lynn (atlanta_3)[1][1]
Gardner, lynn (atlanta_3)[1][1]Gardner, lynn (atlanta_3)[1][1]
Gardner, lynn (atlanta_3)[1][1]Eugene Elwell
 
Salivary Diagnosis
Salivary DiagnosisSalivary Diagnosis
Salivary DiagnosisZaidAhmad42
 
Dr. Rebecca Pentecost: Pennsylvania Llama and Alpaca Association 2011
Dr. Rebecca Pentecost: Pennsylvania Llama and Alpaca Association 2011 Dr. Rebecca Pentecost: Pennsylvania Llama and Alpaca Association 2011
Dr. Rebecca Pentecost: Pennsylvania Llama and Alpaca Association 2011 changingconnections
 
Rebecca Pentecost DVM: PLAA 2011 Keynote Slides
Rebecca Pentecost DVM: PLAA 2011 Keynote SlidesRebecca Pentecost DVM: PLAA 2011 Keynote Slides
Rebecca Pentecost DVM: PLAA 2011 Keynote SlidesRJ Stangherlin
 
Developing diagnostic test for plant, human and animal diseases
Developing diagnostic test for plant, human and animal diseasesDeveloping diagnostic test for plant, human and animal diseases
Developing diagnostic test for plant, human and animal diseasesSushant Balasaheb Jadhav
 
691632.ppt
691632.ppt691632.ppt
691632.pptShinee13
 
Quality Control In Clinical Laboratory
Quality Control In Clinical LaboratoryQuality Control In Clinical Laboratory
Quality Control In Clinical LaboratoryDr. Rajesh Bendre
 
Useful Microbiological Testing in Food Safety and Quality Management
Useful Microbiological Testing in Food Safety and Quality ManagementUseful Microbiological Testing in Food Safety and Quality Management
Useful Microbiological Testing in Food Safety and Quality Managementdedmark
 
Susan_Hicks_Resume_Mar2016
Susan_Hicks_Resume_Mar2016Susan_Hicks_Resume_Mar2016
Susan_Hicks_Resume_Mar2016Susan Cho Hicks
 
Quality assurance in haematology
Quality assurance in haematologyQuality assurance in haematology
Quality assurance in haematologyIshwar Bihana
 

Similar to Raamsdonk beijing immunoassay validation v2 (20)

Dr. Brian Payne - PCV2: Diagnostics, Control, Protection, and Efficacy Measures
Dr. Brian Payne - PCV2: Diagnostics, Control, Protection, and Efficacy MeasuresDr. Brian Payne - PCV2: Diagnostics, Control, Protection, and Efficacy Measures
Dr. Brian Payne - PCV2: Diagnostics, Control, Protection, and Efficacy Measures
 
Cladman wendy cv and addendum 2012
Cladman wendy  cv and addendum 2012Cladman wendy  cv and addendum 2012
Cladman wendy cv and addendum 2012
 
Cladman wendy cv 2012
Cladman wendy  cv 2012Cladman wendy  cv 2012
Cladman wendy cv 2012
 
Mtr corporate
Mtr corporateMtr corporate
Mtr corporate
 
Cladman, wendy cv and addendum
Cladman, wendy  cv and addendum Cladman, wendy  cv and addendum
Cladman, wendy cv and addendum
 
A Novel approach for quantitative real-time particle analysis of lentiviral v...
A Novel approach for quantitative real-time particle analysis of lentiviral v...A Novel approach for quantitative real-time particle analysis of lentiviral v...
A Novel approach for quantitative real-time particle analysis of lentiviral v...
 
Cambridge oncometrix 230317
Cambridge oncometrix 230317Cambridge oncometrix 230317
Cambridge oncometrix 230317
 
Gardner, lynn (atlanta_3)[1][1]
Gardner, lynn (atlanta_3)[1][1]Gardner, lynn (atlanta_3)[1][1]
Gardner, lynn (atlanta_3)[1][1]
 
Gardner, lynn (atlanta_3)[1][1]
Gardner, lynn (atlanta_3)[1][1]Gardner, lynn (atlanta_3)[1][1]
Gardner, lynn (atlanta_3)[1][1]
 
Salivary Diagnosis
Salivary DiagnosisSalivary Diagnosis
Salivary Diagnosis
 
Dr. Rebecca Pentecost: Pennsylvania Llama and Alpaca Association 2011
Dr. Rebecca Pentecost: Pennsylvania Llama and Alpaca Association 2011 Dr. Rebecca Pentecost: Pennsylvania Llama and Alpaca Association 2011
Dr. Rebecca Pentecost: Pennsylvania Llama and Alpaca Association 2011
 
Rebecca Pentecost DVM: PLAA 2011 Keynote Slides
Rebecca Pentecost DVM: PLAA 2011 Keynote SlidesRebecca Pentecost DVM: PLAA 2011 Keynote Slides
Rebecca Pentecost DVM: PLAA 2011 Keynote Slides
 
Developing diagnostic test for plant, human and animal diseases
Developing diagnostic test for plant, human and animal diseasesDeveloping diagnostic test for plant, human and animal diseases
Developing diagnostic test for plant, human and animal diseases
 
09.11.20 | Review of New Antiretrovirals
09.11.20 | Review of New Antiretrovirals09.11.20 | Review of New Antiretrovirals
09.11.20 | Review of New Antiretrovirals
 
Phenotypic and Molecular Detection of Mycobacterium avium subsp. paratubercul...
Phenotypic and Molecular Detection of Mycobacterium avium subsp. paratubercul...Phenotypic and Molecular Detection of Mycobacterium avium subsp. paratubercul...
Phenotypic and Molecular Detection of Mycobacterium avium subsp. paratubercul...
 
691632.ppt
691632.ppt691632.ppt
691632.ppt
 
Quality Control In Clinical Laboratory
Quality Control In Clinical LaboratoryQuality Control In Clinical Laboratory
Quality Control In Clinical Laboratory
 
Useful Microbiological Testing in Food Safety and Quality Management
Useful Microbiological Testing in Food Safety and Quality ManagementUseful Microbiological Testing in Food Safety and Quality Management
Useful Microbiological Testing in Food Safety and Quality Management
 
Susan_Hicks_Resume_Mar2016
Susan_Hicks_Resume_Mar2016Susan_Hicks_Resume_Mar2016
Susan_Hicks_Resume_Mar2016
 
Quality assurance in haematology
Quality assurance in haematologyQuality assurance in haematology
Quality assurance in haematology
 

Recently uploaded

The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin ClassesCeline George
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxVishalSingh1417
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Disha Kariya
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...christianmathematics
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterMateoGardella
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfSanaAli374401
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 

Recently uploaded (20)

The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 

Raamsdonk beijing immunoassay validation v2

  • 1. Immunoassay validation for monitoring ruminant proteins in aquafeed L.W.D. van Raamsdonk, M. Bremer, RIKILT Wageningen R. Margry, R. van Kaathoven, CCL, Veghel
  • 2. Animal proteins monitoring • Microscopy: screening; visible particles • PCR: identification; DNA • Near Infrared spectroscopy / microscopy • Immunoassays: screening or confirmation; proteins • Other L.W.D. van Raamsdonk et al., Beijing, Feedsafety conference, 12-9-2012
  • 3. Animal proteins in aquafeed Aquafeed Non-ruminant PAP 25% 2% Fishmeal 10% gut content Feed for weaning ruminants 5% L.W.D. van Raamsdonk et al., Beijing, Feedsafety conference, 12-9-2012
  • 4. Animal proteins in aquafeed EFSA critical limit: 2% ruminant-PAP in non-ruminant PAP (EFSA, 2011) Concentration of PAP in ruminant feed: 0.25 * 0.1 * 0.05 = 0.00125% LOD microscopy: 0.0025 % (Veys et al., 2009) EFSA critical limit: 0.1% AP in feed (EFSA, 2011) Current scenario: 0.000025% of ruminant PAP in ruminant feed L.W.D. van Raamsdonk et al., Beijing, Feedsafety conference, 12-9-2012
  • 5. Animal proteins in aquafeed Non-ruminant PAP aquafeed monitoring 2% < 2%: Certification for aquafeed 25% fishmeal 10% Ruminant feed 5% < 0.1%: Approved as feed L.W.D. van Raamsdonk et al., Beijing, Feedsafety conference, 12-9-2012
  • 6. Immunoassays (EFSA, 2011) L.W.D. van Raamsdonk et al., Beijing, Feedsafety conference, 12-9-2012
  • 7. Immunoassay validation; in house validation MELISA-TEK Matrix: porcine proteins RR 1 (133°C) 18.0 RR 3 (141°C) RR 4 (145°C) Mean OD sample - Mean OD blank (450nm) RR 2 (137°C) 16.0 14.0 12.0 10.0 8.0 6.0 4.0 2.0 0.0 0.0 0.5 1.0 Spike rate (%) 1.5 2.0 L.W.D. van Raamsdonk et al., Beijing, Feedsafety conference, 12-9-2012
  • 8. Immunoassay validation; in house validation MELISA-TEK • Specificity and robustness TN FP Porcine PAP 27 0 Poultry PAP 21 1 Other material * 9 0 Milk powder 2 0 Threshold: mean OD ratio + 3 * SD *: blood plasma, porcine DCP/TCP, feather meal, fish meal, gelatine L.W.D. van Raamsdonk et al., Beijing, Feedsafety conference, 12-9-2012
  • 9. Immunoassay validation; interlaboratory study • MELISA-TEK and Reveal • 16 participants • Three parts: training samples, entrance test, final study • After entrance test: 14 participants • Period: January to May 2012 • AOAC guidelines, as far as applicable L.W.D. van Raamsdonk et al., Beijing, Feedsafety conference, 12-9-2012
  • 10. Immunoassay validation; results Melisa-Tek • Accuracy (n=84) 133 ºC Blank 137 ºC 98.8% 0.5% 100% 1.0% 100% 100% 2.0% 100% 100% L.W.D. van Raamsdonk et al., Beijing, Feedsafety conference, 12-9-2012
  • 11. Immunoassay validation; results Reveal • Accuracy (n=84) 133 ºC Blank 137 ºC 97.0% 0.5% 100% 1.0% 98.8% 98.8% 2.0% 100% 100% L.W.D. van Raamsdonk et al., Beijing, Feedsafety conference, 12-9-2012
  • 12. Immunoassay; future strategy • Current situation: performance limit (0.5% < 2.0%) approved • Future target: performance limit: 0.1% • Option: concentration experiments for target (= troponine) L.W.D. van Raamsdonk et al., Beijing, Feedsafety conference, 12-9-2012
  • 13. Immunoassay; conclusions • Immunoassays (Melisa-Tek and Reveal) are validated at 0.5% and higher with PAP as matrix • A strategy with immunoassays will avoid the presence of positive signals for legally applied ingredients • The design of the study can be used as guideline for future studies with qualitative results • Application of immunoassays after muscle concentration could be feasible to reach the 0.1% performance limit L.W.D. van Raamsdonk et al., Beijing, Feedsafety conference, 12-9-2012